Read + Share
Amedeo Smart
Independent Medical Education
Eldani C, Darrigade AS, Beylot-Barry M, Jullie ML, et al. Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as "toxic epidermal necrolysis-like". Eur J Dermatol 2022;32:805-807.PMID: 36856394
Email
LinkedIn
Facebook
Twitter
Privacy Policy